Funder: ThyCa: Thyroid Cancer Survivors' Association
Due Dates (Anticipated): March 2027 (Proposal submission)
Funding Amounts: Up to $20,000 through the AAES ThyCa Award
Summary: Supports research worldwide on all types of thyroid cancer, from cancer biology and treatments to clinical outcomes and survivorship.
Key Information: Partner-society requirements apply; the AAES award targets investigators less than 10 years from training without prior independent NIH funding.
Description
ThyCa: Thyroid Cancer Survivors’ Association has funded annual research grants since 2003 to help cure all types of thyroid cancer. Its General Thyroid Cancer Research Fund covers papillary, follicular, variant, poorly differentiated, and anaplastic thyroid cancers, while its Medullary Thyroid Cancer Research Fund supports medullary disease. Supported work examines cancer development, genetic changes, immune responses, treatment resistance, therapeutic targets, clinical outcomes, survivorship, and disparities in care.
The program works with the American Thyroid Association (ATA), American Association of Endocrine Surgeons (AAES), and American Head and Neck Society (AHNS). Independent expert panels review proposals and recommend awards, with ThyCa making final selections. Grants are awarded on scientific merit regardless of institutional affiliation. Through the ATA partnership, ThyCa prioritizes at least one follicular-cell thyroid cancer project and one medullary thyroid cancer project annually.
